TP53 and esophageal squamous cell carcinoma: Similarly, pooled analysis of studies including pure ESCC cohorts showed p53 high expression is associated with a statistically significant poor outcome with lower heterogeneity (HR: 1.34, 95% CI: 1.20–1.51, n = 47, I2=39%, P for interaction = 0.60; Fig. 3).